Tech Company Financing Transactions

Cardioxyl Pharmaceuticals Funding Round

Cardioxyl Pharmaceuticals, based in Chapel Hill, received $6 million from Aurora Funds and private investors.

Transaction Overview

Announced On
12/31/2008
Transaction Type
Venture Equity
Amount
$6,000,000
Round
Undisclosed
Investors

Aurora Funds (Christopher Kroeger)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
1450 Raleigh Rd. 212
Chapel Hill, NC 27517
USA
Email Address
Overview
Cardioxyl Pharmaceuticals' mission is the discovery and development of newclasses of safe and effective therapeutic agents for the treatment ofcardiovascular disease. Cardioxyl's initial program is a novel medication forthe treatment of acute decompensated heart failure.
Profile
Cardioxyl Pharmaceuticals LinkedIn Company Profile
Social Media
Cardioxyl Pharmaceuticals Company Twitter Account
Company News
Cardioxyl Pharmaceuticals News
Facebook
Cardioxyl Pharmaceuticals on Facebook
YouTube
Cardioxyl Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Christopher Kroeger
  Christopher Kroeger LinkedIn Profile  Christopher Kroeger Twitter Account  Christopher Kroeger News  Christopher Kroeger on Facebook
Chief Medical Officer
Shi Foo
  Shi Foo LinkedIn Profile  Shi Foo Twitter Account  Shi Foo News  Shi Foo on Facebook
Chief Scientific Officer
John Reardon
  John Reardon LinkedIn Profile  John Reardon Twitter Account  John Reardon News  John Reardon on Facebook
VP - Regulatory Affairs
Doug Cowart
  Doug Cowart LinkedIn Profile  Doug Cowart Twitter Account  Doug Cowart News  Doug Cowart on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/31/2008: TriReme Medical venture capital transaction
Next: 12/31/2008: Scintera Networks venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on all VC transactions involving tech companies. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary